Add BrightSurf on Google Email

Neural Regeneration Research


Autophagy and neurodegenerative disorders

A review article by Kesidou et al. explores the molecular mechanisms of autophagy and its role in chronic and acute neurodegenerative disorders. The study highlights the complex interplay between autophagy's protective and damaging effects, emphasizing the need for further research to fully understand its implications.

SourceNeural Regeneration Research·JournalNeural Regeneration Research·DateSep 12, 2013

Hydrolyzed or non-hydrolyzed collagen: which one is suitable for nerve cell culture?

A study published in Neural Regeneration Research found that hydrolyzed collagen is suitable for nerve cell culture due to its ability to facilitate cell survival and neurite outgrowth. Non-hydrolyzed collagen matrices had no obvious effects on these processes, making hydrolyzed collagen a promising tool for neural tissue engineering.

SourceNeural Regeneration Research·JournalNeural Regeneration Research·DateSep 5, 2013

Simulating Alzheimer's disease in transgenic mice

Researchers have developed an animal model to simulate the pathological process of Alzheimer's disease, focusing on the locus coeruleus. This study shows that degenerative alterations in noradrenergic neurons of the locus coeruleus are consistent with pathological changes observed in patients with Alzheimer's disease.

SourceNeural Regeneration Research·JournalNeural Regeneration Research·DateSep 5, 2013

Post-traumatic stress disorder in a rescue group after the Wenchuan earthquake relief

A recent study examined post-traumatic stress disorder (PTSD) in a group of 1,040 rescue workers who participated in the Wenchuan earthquake relief. The findings indicate that PTSD was diagnosed in 64% of the participants, primarily due to factors such as near-death experience, severe injury or mental trauma, and low social support.

SourceNeural Regeneration Research·JournalNeural Regeneration Research·DateAug 14, 2013

X-linked MeCP2 is first reported to be a new target for treating Parkinson's disease

A new study published in Neural Regeneration Research suggests that X-linked methyl-CpG binding protein 2 (MeCP2) may be a promising therapeutic target for treating Parkinson's disease. Researchers found that overexpressing MeCP2 in damaged human cells reduced apoptosis and increased tyrosine hydroxylase levels, indicating potential be...

SourceNeural Regeneration Research·JournalNeural Regeneration Research·DateAug 11, 2013